v3.26.1
Note 2 - IPO and Restructuring (Details Textual)
 6 Months Ended 59 Months Ended
Mar. 07, 2025
USD ($)
$ / shares
shares
Jun. 30, 2026
USD ($)
shares
Jun. 30, 2025
USD ($)
Mar. 06, 2025
shares
Dec. 31, 2025
shares
Feb. 20, 2025
shares
Proceeds from Issuance of Common Stock | $   $ 0 $ 5,032,000      
Common Stock, Shares Authorized (in shares) 50,000,000 50,000,000     50,000,000  
Preferred Stock, Shares Authorized (in shares) 25,000,000 25,000,000       25,000,000
Master Exchange Agreement [Member]            
Restructuring, Common Stock Shares Outstanding, Percentage 0.96          
Debt Instrument, Exchanged Face Amount | $ $ 1,143,646          
Debt Conversion, Original Debt, Amount | $ 1,006,377          
Debt Conversion, Interest | $ $ 137,269          
Master Exchange Agreement [Member] | BP Peptides, LLC [Member]            
Restructuring, Related Party Ownership, Percentage Pre-restructuring 0.773          
Restructuring, Related Party Ownership, Percentage Post-restructuring 0.03          
Master Exchange Agreement [Member] | BPA XIV, LLC [Member]            
Restructuring, Related Party Ownership, Percentage Post-restructuring 0.64          
Master Exchange Agreement [Member] | Conversion of Total Stones Class B and C Preferred Interests Into Common Stock [Member]            
Conversion of Stock, Shares Issued (in shares) 3,782,641          
Class A Common Interests, Warrants [Member]            
Class of Warrant or Right, Cancelled During Period (in shares) 1,125     50    
Class A Common Interests, Warrants [Member] | TotalStone [Member]            
Class of Warrant or Right, Cancelled During Period (in shares) 1,125          
IPO [Member]            
Stock Issued During Period, Shares, New Issues (in shares) 1,250,000          
Shares Issued, Price Per Share (in dollars per share) | $ / shares $ 4          
Proceeds from Issuance of Common Stock | $ $ 3,252,000